Abdullah Ozkaya - Publications

Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.

Journal: European journal of ophthalmology

Published: August 22, 2026

Real-world evaluation of anti-VEGF therapy in diabetic macular edema: The role of macular ischemia and OCT biomarkers BOSPHORUS DME study group report no: 14.

Journal: European journal of ophthalmology

Published: July 24, 2026

Assessment of Dietary Nutritional Profile in Turkish Patients with Age-Related Macular Degeneration.

Journal: Turkish journal of ophthalmology

Published: June 25, 2026

Evaluation of anti-VEGF response in diabetic macular edema patients with baseline DRIL: a multicenter real-world study (BOSPHORUS-DME Study Group Report No.16).

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: February 21, 2026

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Türkiye: 48-Month Data, BOSPHORUS-DME Study Group Report No. 1.

Journal: Turkish journal of ophthalmology

Published: February 18, 2026

Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5.

Journal: Clinical & experimental optometry

Published: January 06, 2026

Imaging biomarkers associated with visual acuity in central serous chorioretinopathy: a multimodal analysis.

Journal: International ophthalmology

Published: August 07, 2025

Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group.

Journal: European journal of ophthalmology

Published: September 05, 2024

One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13.

Journal: Seminars in ophthalmology

Published: August 01, 2024

Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5.

Journal: Eye (London, England)

Published: April 15, 2024

Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10.

Journal: International ophthalmology

Published: March 24, 2024

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1.

Journal: Turkish journal of ophthalmology

Published: December 21, 2023